HealthEquity (NASDAQ:HQY) Price Target Increased to $103.00 by Analysts at Deutsche Bank Aktiengesellschaft

HealthEquity (NASDAQ:HQY) had its price objective increased by Deutsche Bank Aktiengesellschaft from $102.00 to $103.00 in a research note published on Wednesday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

HQY has been the subject of a number of other research reports. Barrington Research reiterated an outperform rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, August 30th. Bank of America cut their price objective on shares of HealthEquity from $105.00 to $100.00 and set a buy rating for the company in a research report on Wednesday. Raymond James raised their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an outperform rating in a research report on Friday, June 7th. Wells Fargo & Company boosted their price target on HealthEquity from $107.00 to $110.00 and gave the company an overweight rating in a report on Thursday, June 20th. Finally, Royal Bank of Canada restated an outperform rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and a consensus price target of $103.83.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $76.24 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. The business’s fifty day moving average price is $77.03 and its two-hundred day moving average price is $79.66. The stock has a market cap of $6.63 billion, a PE ratio of 82.87, a price-to-earnings-growth ratio of 1.34 and a beta of 0.52. HealthEquity has a one year low of $61.81 and a one year high of $88.26.

Insider Buying and Selling

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Frank Corvino sold 7,705 shares of the company’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the sale, the director now directly owns 6,070 shares of the company’s stock, valued at $497,072.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 75,031 shares of company stock valued at $6,103,625. 2.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently bought and sold shares of HQY. Motley Fool Asset Management LLC grew its position in HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after acquiring an additional 3,640,748 shares in the last quarter. Norges Bank purchased a new stake in HealthEquity during the 4th quarter worth $43,482,000. Vaughan Nelson Investment Management L.P. acquired a new position in HealthEquity in the 1st quarter worth $49,443,000. Wasatch Advisors LP boosted its position in HealthEquity by 8.3% in the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after buying an additional 569,249 shares during the last quarter. Finally, Mackenzie Financial Corp grew its stake in shares of HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after acquiring an additional 325,906 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.